Welcome to the e-CCO Library!

P355 Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Buisson1, M. Fumery2, M. Serrero3, L. Orsat1, S. Nancey4, P. Rivière5, R. Altwegg6, L. Peyrin-Biroulet7, M. Nachury8, X. Hébuterne9, C. Gilletta10, M. Flamant11, S. Viennot12, G. Bouguen13, A. Amiot14, S. Mathieu15, L. Vuitton16, L. Plastaras17, A. Bourreille18, L. Caillo19, F. Goutorbe20, M. Fumery21, G. Pineton de Chambrun6, A. Attar22, X. Roblin23, B. Pereira24, B. Pariente8

Created: Thursday, 30 January 2020, 10:12 AM
P355: A structured care pathway improves quality of care for acute severe ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Neary B., Doherty G., Rafter N., Gibson D.

Created: Wednesday, 20 February 2019, 10:36 AM
P355: Diagnostic accuracy and usability of home calprotectin testing
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Thomas*1, M. Clarke1, V. Cairns1, J. Goodhand1, T. Ahmad1, N. Kennedy1

Created: Friday, 22 February 2019, 9:41 AM
P355: Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Seah*1, 2, M. Choy1, 2, 3, A. Gorelik4, F. Macrae5, M. Sparrow6, W.R. Connell3, G. Moore7, D. Van Langenberg8, P. De Cruz1, 2

Created: Friday, 22 February 2019, 9:49 AM
P355: Exceeding treatment expectations in Crohn's disease: transmural healing and a new definition of deep remission
Year: 2022
Source: ECCO'22
Authors: Castiglione, F.(1);Imperatore, N.(1);Testa, A.(1);de Sire, R.(1);Nardone, O.M.(1);Ricciolino, S.(1);Di Luna, I.(1);Patturelli, M.(1);Villani, G.D.(1);Olmo, O.(1);Rispo, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P355: Motility in small bowel strictures in Crohn's Disease measured with cine-MRI
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Beek, K.(1)*;de Jonge, C.S.(1);van Rijn, K.(1);de Voogd, F.A.E.(2);Buskens , C.J.(3);D'Haens , G.(2);Gecse, K.B.(2);Stoker, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P355: Preferences and satisfaction of IBD patients in whom the adalimumab regimen was changed from 40 mg weekly to 80 mg every other week: the ADASCAL study
Year: 2021
Source: ECCO'21 Virtual
Authors: Taxonera Samso, C.(1);Martínez-Montiel, P.(2);Barreiro-De-Acosta, M.(3);Vera, I.(4);Lorente, R.(5);Vega, P.(6);Diz-Lois, M.T.(7);Fuentes Coronel, A.M.(8);Pérez Calle, J.L.(9);Casis, B.(2);Ferreiro, R.(3);Calvo, M.(4);Olivares, D.(1);Alba, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P355: Prevalence, clinical characteristics and outcomes of CMV colitis in a cohort of 95 patients with ulcerative colitis: A 7-year retrospective analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Carvão1*, J. Alves2, V. Magno Pereira1, C. Sousa Andrade1, H. Morna1, G. Andrade2, L. Jasmins1

Created: Thursday, 21 February 2019, 9:14 AM
P356 Infectious events in patients with inflammatory bowel disease: The impact of immunomodulators and tumour necrosis factor antagonist therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Andersson, P. Karling

Created: Thursday, 30 January 2020, 10:12 AM
P356: A comparison of innovative strategies to promote engagement with an IBD patient portal
Year: 2021
Source: ECCO'21 Virtual
Authors: Carlson, S.(1);McCartney, S.(1);Harrow, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P356: CRAB Score, An Indian Insight into in hospital and long-term Colectomy following Acute Severe Ulcerative Colitis (ASUC)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Varghese, J.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P356: Czech experience with treatment of Crohn´s disease perianal fistulas by allogenic mesenchymal stem cell
Year: 2022
Source: ECCO'22
Authors: Serclova, Z.(1);Lengálová, M.(1);Zusková, P.(1);Tremerová, A.(1);Drvostepova, L.(1);
Created: Friday, 11 February 2022, 3:52 PM
P356: Efficacy and safety of certolizumab pegol in Crohn’s disease patients with loss of response or intolerance to previous anti-TNF
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

I. Ferrer Bradley*1, I. Marín2, N. Maroto1, M. Mora1, E. Hinojosa1, B. López2, L. Menchén2, J. Hinojosa1

Created: Friday, 22 February 2019, 9:49 AM
P356: Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in paediatric patients with inflammatory bowel disease: a multi-centre cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Toita*1, H. Tanaka2, K. Arai3, H. Shimizu3, D. Abukawa4, T. Kobayashi5, N. Yoshimura6, S. Tanida7, E. Hosoi8

Created: Friday, 22 February 2019, 9:41 AM
P356: The role of endoscopic activity in the coagulation profile of clinical remission Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Andrade*, M. Azevedo, A. Carlos, C. Hashimoto, A. Sipahi, A. Damião, E. D´Amico, A. Leite

Created: Thursday, 21 February 2019, 9:14 AM
P356: Treatment with anakinra induces T cell production of IL22 and GI mucosal healing in an IL-10RA mutation patient
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Li J.1, Shouval D.2, Doty A.1, Snapper S.3, Glover S.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P357 Importance of stool drug monitoring in anti-TNF-treated patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Bacsur1, K. Szántó1, T. Madácsy1, D. Kata1, T. Ferenci2, M. Rutka1, A. Bálint1, R. Bor1, A. Fábián1, Á. Milassin1, G. Elekes3, Z. Szepes1, F. Nagy1, I. Földesi3, J. Maléth1, K. Farkas1, T. Molnár1

Created: Thursday, 30 January 2020, 10:12 AM
P357: A multi-institutional report of postoperative outcomes in Vedolizumab-Treated patients undergoing major abdominal operations for inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lightner A.*1, Mathis K.2, Sang Tse C.3, Pemberton J.1, Shen B.4, Kocklar G.4, Singh A.4, Parambir D.5, Eisenstein S.6, Stringfield S.5, Hudesman D.7, Remzi F.8, Loftus E.3

Created: Wednesday, 20 February 2019, 10:36 AM
P357: Do you think that complementary and alternative medicine use is frequent amongst inflammatory bowel disease patients: Forget it!—results from a comparative study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Rutka*1, T. Ferenci2, F. Nagy1, Z. Szepes1, K. Farkas1, A. Bálint1, R. Bor1, A. Milassin1, Z. Lénárt1, T. Molnar1

Created: Friday, 22 February 2019, 9:49 AM
P357: Healthcare and medication utilisation in Singapore adult inflammatory bowel disease patients receiving immunomodulators and biologics
Year: 2018
Source: ECCO '18 Vienna
Authors:

R.E.L. Gan1,2,3, C.K.Y. Ng1, W.C. Ong1, W.P.W. Chan2,3, B.J. Schwender2,3, S.C. Kong2,3, H.H. Shim2,3, K.L. Ling2,3, S.W. Chuah2,3, T.G. Lim1,3*

Created: Thursday, 21 February 2019, 9:14 AM